Although bronchial hyperresponsiveness to cholinergic agents is a main feature of asthma, the role of anticholinergic drugs in chronic asthma management has been largely underestimated.
Increased ET-1 levels have been demonstrated in the bronchial epithelium of asthma patients. In vitro, ET-1 stimulates mucus secretion, activates proinflammatory cells - macrophages and mast cells ...
Dec. 25, 2024 — A new method of scanning lungs is able to show in real time how air moves in and out of the lungs as people take a breath in patients with asthma, chronic obstructive pulmonary ...
Some scientists believe that asthma and vitamin deficiencies are linked. It is thought that certain vitamins—most specifically vitamin D, vitamin C, and vitamin E—play a role in not only the ...
GSK’s follow-up to its severe asthma therapy Nucala has shown its value in a pair of phase 3 trials, reducing exacerbations compared to placebo with dosing once every six months. The company ...
GSK's new long-acting drug candidate for severe asthma, depemokimab, reduced the rate of severe attacks by 54% in a pair of phase 3 trials presented at the European Respiratory Society (ERS ...
July 15, 2024 — Early exposure to antibiotics can trigger long term susceptibility to asthma, according to new research. Importantly the research team isolated a ... Could a Dietary Fiber ...
As complaints stack up every year about the atmosphere at many high-profile music festivals, If anyone ever wants to go to one that is nearly 100% free from toxic masculinity, one candidate comes ...